Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary cocktail with thrombus aspiration in STEMI
NCT02592694Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tirofiban, bivalirudin and tenecteplase in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Death, Myocardial Infarction, NYHA IV Heart Failure at 1 year. Status: unknown.
02
Drugs
tirofibanbivalirudintenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02592694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592694.